Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.
Details
Industries BiotechnologyLife ScienceTherapeuticsHeadquarters Regions San Francisco Bay Area, West Coast, Western US Founded Date 2018 Founders Jeffrey Greve Operating Status Active Last Funding Type Series B Legal Name Kyverna Therapeutics, Inc.
Stock Symbol NASDAQ:KYTX Company Type For Profit
Contact Email info@kyvernatx.com
KYVERNA is pioneering a new class of treatments and potential cures for serious autoimmune diseases. The company's therapeutic platform combines advanced T-cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the root cause of inflammatory diseases.
Products and Services
Product Name | Product Description |
---|---|